The study of the effectiveness of cryotherapy as a curative treatment for prostate cancer has often relied on the use of either in vitro cell culture monolayers or animal models. While the data gleaned from these studies have been valuable, each model has inherent limitations.
Introduction
Cancer is the second leading cause of death in the US claiming approximately 570,000 lives in 2005. Of those deaths, over 30,000 were from prostate cancers, making it the second leading cancer killer among men (1) . Current treatment modalities include surgical ablation, external beam radiation, brachytherapy, RF treatment, and chemotherapy. Cryosurgery, the utilization of low temperatures to freeze and destroy unwanted tissue, has also emerged as a common option in the treatment of cancerous lesions (2-4). Like any therapy, improving cryosurgical efficacy requires an understanding of both the physical parameters of the treatment itself, as well as the cellular and biochemical responses of the targeted tissue (cells) to that treatment.
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Cryosurgery is performed through the application of a heat sink (cryoprobe) to a desired area in order to generate a rapid cooling rate and subsequent generation of a frozen mass of tissue, the cryolesion. This lesion is physically characterized by a thermal gradient with the lowest temperature nearest the cryoprobe and -0.5 ºC at the freeze zone periphery with the formation of both intra-and extracellular ice (5). Cells are initially destroyed through either a freeze rupture, a physical destruction of the cells throughout much of the lesion, or through a necrotic process resulting from chemical and osmotic stresses induced during freezing (6). Apoptosis, or programmed cell death, has also been shown to be a major contributor to cell death following cryosurgery, typically associated with the freeze zone periphery and occurs in a time frame ranging over hours to days post-thaw (2, 7-9). Additionally, the formation and propagation of this freeze zone and its associated cell death mechanisms represent a dynamic process occurring in real time and in 3-dimensions. As such, it is essential that an experimental model be employed that is able to accommodate these complexities.
To that end, a number of in vitro and in vivo experimental model systems are currently available for the study of the molecular mechanisms underlying prostate cancer initiation, progression, or treatment responsiveness. These include hormonal or carcinogen-induced prostate cancer rodent models (6, 10), oncogene over expression-induced prostate cancer (11), transplantable human prostate cancers (12), and established human prostate cancer cell lines (13-15). Cancer cells are highly variable, both phenotypically and genotypically, and their gene expression and cellular behavior are easily modulated by extracellular environments and culture conditions (16, 17) . Typical monolayer or 2-dimentional (2D) in vitro models, though easy to assess and visualize, lack the complete cell-cell and cell-matrix interactions that can affect cell behavior and do not allow for the complex architecture of a cryolesion. While in vivo models provide for these complex interactions and the formation of a complete cryolesion, specific variables are difficult or impossible to assess or isolate.
We describe in this study the development and validation of a novel 3-dimentional (3D) culture system, an engineered prostate, for the evaluation of cryosurgical procedures. Utilizing this model, a more in vivo-like environment is created in which to support the study of the effects of cryosurgery (18). The resulting tissue-like structures more realistically model the structural architecture and differentiated function of human cancers (19), and may give rise to the formation of microstructures (20) . This model allows for more complex cell-cell/ matrix interactions, vascular simulations, multiple cell types, and the formation of a cryolesion with the ease of assessment typically reserved for 2D cultures. It is our aim to utilize such a model to provide for greater insights into the molecular based responses of cancer cells to cryoablative techniques.
Materials and Methods

Cell and 3D Cultures
The human prostate cancer PC-3 cell line was obtained from the American Type Culture Collection (Rockville, MD), and maintained at 37 ºC, 5% CO 2 /95% air in RPMI-1640 culture medium (Caisson Laboratories Inc., Sugar City, ID) fortified with 10% fetal calf serum (Atlanta Biologics Inc., Atlanta, GA) and 1% penicillin/streptomycin (Mediatech Inc., Herndon, VA). Cells were cultured in Falcon 75 cm 2 t-flasks with media replenishment every three days. All experiments were performed on cells between passages 3 and 15.
Rat tail type I collagen solution (BD Bioscience, Bedford, MA) was used to form gel matrices as per manufacturer's directions. Cells, 1.25, 2.5, or 5 × 10 6 cells/mL, were directly suspended in the collagen solution prior to gel solidification in Falcon 24-well plates, 35 mm Petri dishes, or 40 mm stainless steel rings. The matrices were cultured 24 hr prior to freezing or addition of chemotoxic agents, and media was replenished every day. For cryotherapy in conjunction with chemotherapeutic agents, cis-platinum (Sigma Aldrich, St. Louis, MO), Taxotere (provided by Drs. Cohen and Miller at Triangle Urology, Pittsburgh, PA), and TNF-related apoptosis-inducing ligand (TRAIL, Biomol International, Plymouth Meeting, PA) were added to the media 48 or 24 hr prior to freezing. The 3D prostate models were formed by layering gel matrices on top of one another for the freezing process.
Cryoablation
A SeedNet® Gold cryosurgical system with 17-gauge argon/ helium needle cryoprobes (Oncura Inc., Plymouth Meeting, PA) was utilized for the freezing process. Briefly, a single cryoprobe was placed into the center of the collagen matrix (35 mm dish or stack of 40 mm stainless steel rings) and a single or double freeze cycle was initiated consisting of a 10 min freeze followed by 20 min of thawing at 37 ºC. The temperature profile of the freeze zone was recorded with an array of copper-constantan (type T) thermocouples placed equidistant and extending radially from the probe tip using an Omega TempScan 1100 (Omega, Stamford, CT). Once thawed, samples were either returned to culture or five sets of four, 2 mm diameter punches (refer to Figure 4 ) were removed to falcon 96-well plates containing 125 μL/well culture medium for viability assessments.
Cell Viability
Cell viability assessment was performed on matrices in 24-well plates and on punches removed from frozen/thawed matrices, using the alamarBlue™ (Trek Diagnostics, Cleveland, OH) metabolic activity assay. Culture medium from punch-containing 96-well plates or matrix-containing 24-well plates was decanted and 100 or 500 μl/well of the working alamarBlue™ solution was added. Samples were then incubated in the dark at 37 ºC for 60 min (±1 min). Fluorescence was evaluated using a Tecan SPECTRAFluorPlus plate reader (TECAN, Austria GmbH) with a 530 nm excitation/590 nm emission filter set. Following assessment, the alamarBlue™ was decanted, 125 or 1000 μL/well culture media was added, and the plates were returned to culture. The 2 mm diameter punches remained in the wells for the duration of the viability assay, and a minimum of three experimental repeats were performed.
Cell Death Analysis
Both matrix models were assessed for the presence of live and dead cells using calcein AM and propidium iodide (PI) (Molecular Probes, Eugene, OR), or apoptotic, necrotic, and live cells using the Vybrant Apoptosis assay (Molecular Probes) following the manufacturer's protocol. Fluorescent staining was visualized using a Zeiss Axiovert 200 fluorescent microscope with the AxioVision 4 software (Zeiss, Germany). A 50X panoramic series of fluorescent micrographs was taken generating an image slice extending from the center (cryoprobe placement) to the edge of each cell matrix. All images are representative of at least three experimental repeats.
Results
Matrix Composition
The evaluation of cryosurgical techniques and the molecular responses of cells to those techniques have been difficult given the concerns over variable limitations in traditional monolayers and uncontrolled variables in animal models during freezing insults. We developed a 3D culture system, an engineered human prostate tumor model, which can better accommodate the dynamic properties inherent to cryosurgery and, thus, support a more in vivo-like analysis of cellular responses. The first steps in developing this model was to ensure that cells survive and proliferate within the collagen matrices and that the various methods of assessment can be successfully employed.
The ability of human prostate PC-3 cells to survive and proliferate 3-dimensionally (i.e., suspended within 3 mm thick collagen matrices) was tested using collagen densities of 1 and 2 mg/mL and initial seed densities of 1.25, 2.5, and 5 × 10 6 cells/mL. Viability assessment of the 3D cultures using alamarBlue™ following 1, 3, and 7 days of incubation revealed that cells were able to survive in the matrices for extended periods regardless of the collagen concentration or the cell seeding density (Fig. 1 ). These data correlate with fluorescent imaging of calcein AM stained cells (data not shown). Furthermore, the rate of cell proliferation within the matrices appeared to be independent of the concentrations and initial seeding densities. Based on these data, a collagen concentration of 2 mg/mL was utilized as the standard matrix composition due to its greater durability with a seeding density of 2.5 × 10 6 cells/mL.
Engineered Prostate Tumor
Following the establishment of matrix, seeding, and assessment parameters, the 3D culture was scaled up to develop the engineered tissue model. Cell containing matrices were formed in 40 mm diameter stainless steel rings at a thickness of 3 mm. The 3D culture rings were layered to form a cylindrical prostate model (40 mm diameter × 30 mm height) just prior to the freeze procedure ( Fig. 2A) . Following the freeze/thaw cycle, the matrices were un-stacked and cultured as individual slices for 24 hr before being assessed with calcein AM and propidium iodide (PI). A panoramic series of fluorescent micrographs was then taken extending radially from the center to the edge of the matrix. End point temperatures, as determined by an array of thermocouples, were then overlaid (Fig. 2B ).
From these images, the extent of cell destruction could be visualized throughout the model. It should be noted that the extent of cell death was considerably smaller than the total volume of the freeze zone. Complete cell destruction occurred below the -40 ºC isotherm. At warmer temperatures, some cells were able to survive the freezing procedure. These data support the clinical goal of achieving temperatures of -40 to -50 ºC to ensure cell death (2, 7). By employing this model, we were able to visualize cellular responses over the entire thermal gradient of the cryolesion, and more accurately map temperature-tocell death/survival relationships in a model more closely mimicking an in vivo prostate cryoablative procedure. 
Modulating Cell Survival
Beyond correlating temperature and cell death, our engineered model provided further experimental detail relevant to clinical experience in cryosurgical procedures. For example, it has long been recognized that repetitive freezing improves treatment outcome over a single freeze/thaw cycle. As such, we investigated the effects of a double freeze/thaw cycle in comparison to a single cycle.
Engineered matrices, representing the middle layer of the above model, were exposed to either a single or double freeze-thaw event, and at 24 hr post-thaw cells were stained with calcein AM and PI. Panoramic fluorescent micrographs were then taken to assess the differences in the extent of cell death (Fig. 3) . These analyses revealed a measurable extension of thermal gradients toward the periphery of the model in the double freeze regime. More importantly, however, the critical temperature, beyond which little cell survival is seen, was shifted. In the single freeze procedure, the critical isotherm was found to be near -40 ºC. In the double freeze/thaw procedure, it was shifted toward the periphery to around -20 to -30 ºC, thereby significantly increasing the overall ablative volume of the cryolesion. Furthermore, in the double freeze procedure, more substantial death was apparent beyond the critical temperature (-30 to -20 ºC). Engineered matrices were frozen by a single, centrally placed 17-gauge cryoprobe and thermocouples at 4 mm intervals extending radially from the center were used to monitor temperatures. Matrices were frozen for either a single or double 10 min freeze followed by a 20 min thaw at 37 ºC 24 hr prior to staining with calcein AM (green, live cells) and propidium iodide (red, dead cells). A 50X panoramic series of fluorescent micrographs was taken extending from the center (left of images) to the edge (right of image).
Figure 4:
Effects of Single vs. Double Freeze on Post-Thaw Viability. Engineered matrices were frozen by a single, centrally placed 17-gauge cryoprobe and thermocouples at 4 mm intervals extending radially from the center were used to monitor temperatures. Matrices were frozen for either a single or double 10 min freeze followed by a 20 min thaw at 37 ºC. Immediately following thawing, a series of 2 mm diameter punches were removed to individual wells of a 96-well plate and assessed with the metabolic indicator alamarBlue™. The diagram depicts the location and sizes of thermocouples and punches within the matrix.
Quantitative analysis of individual, 2 mm diameter punches removed from the model and assessed with the metabolic indictor alamarBlue™ yielded results supporting a shift in the critical isotherm (Fig. 4) . In punches corresponding to a -20 ºC end point temperature, there was a 38% decrease in overall day 1 cell viability in the double freeze as compared to the singe freeze procedure. Comparing viability of cells in the freeze zone periphery (-5 ºC) day 1 values were nearly identical (2248 vs. 2257 raw fluorescent units), indicating that there is a limit to the beneficial destructive effects of double freeze treatments.
In addition to repetitive freezing, adjunctive therapies, using chemotherapeutic agents in conjunction with cryoablation, have also been introduced through in vitro studies as a means of improving cryosurgical efficacy. To examine the potential beneficial effects of this approach, we conducted a series of studies using the tissue engineered model and three chemotherapeutic agents (cis-Platinum, Taxotere, and TRAIL) coupled with single and double freeze treatments. Following freezing, matrices were imaged or 2 mm diameter punches removed as previously described, but 10 μg/mL Taxotere or cis-Platnium were added two days prior to freezing or 1 μg/mL TRAIL was added just prior to freezing. Engineered prostates were exposed to the chemotherapeutic agents during the freeze/thaw cycle and for the first 24 hr of recovery before fluorescent imaging (Fig. 5 ) or metabolic assessment (Fig. 6 ).
Fluorescent images revealed the ability of adjunctive modalities to ablate cells at warmer temperatures; thus, increasing the overall kill volume of the cryolesion (Figs. 5A and B) . The combination of freezing and chemotoxic agents shifted the critical isotherm from -40 ºC to around -30 to -20 ºC in Tissue engineered matrices were frozen by a single, centrally placed 17-gauge cryoprobe and thermocouples at 4 mm intervals extending radially from the center were used to monitor temperatures. Matrices were frozen for either a (A) single or (B) double 10 min freeze followed by a 20 min thaw at 37 ºC. Immediately following thawing, a series of 2 mm diameter punches were removed to individual wells of a 96-well plate and assessed with the metabolic indicator alamarBlue™.
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the single freeze (Fig. 5A ) and from -30 ºC to around -20 to -10 ºC in the double freeze (Fig. 5B) . Using the same concentrations of chemotherapeutic agents on non-frozen cells resulted in little to no cell death (14, 15, 23 , and data not shown) indicating a synergistic effect between the chemotoxic agents and the cold temperatures.
Once again, metabolic assessment at various isotherms supports the fluorescent micrographic analyses (Fig. 6 ). In the double freeze procedure, the addition of Taxotere resulted in a 33% reduction in day 1 viability at -20 ºC where as the freeze/TRAIL combination resulted in a 76% reduction, completely ablating the prostate model at the -20 ºC isotherm (Fig. 6B) . These results indicate that by using the tissue engineered prostate cancer model, we were able to visualize and quantitatively assess in vitro what until now could not be described in vivo.
Molecular Mechanisms of Cell Death
In addition to characterizing the response of prostate cancer to a simulated cryotherapeutic procedure, we utilized the engineered model to investigate the molecular mechanisms underlying cell death associated with cryosurgery. Matrices were frozen, thawed, cultured for 1, 6, 12, or 24 hr, and then imaged. Individual series of matrices were stained with calcein AM and PI (indicating live and necrotic cells) or PI and YoPro 1 (indicating necrotic and apoptotic cells). The image channels were separated and calcein AM was colored blue for clarity. The progression of cell death for the initial 24 hr of post-ablation recovery is illustrated in Figure 7 .
Immediately following the freeze/thaw procedure (1 hr image), a significant decrease in the live cell population was apparent, with the critical isotherm at approximately -40 ºC (Fig. 7A ). Extensive necrotic staining, which includes cells destroyed through a freeze rupture as well as cells in late stage apoptosis, was seen throughout the freeze zone with levels tapering off near the periphery (Fig. 7B) , and a significant population of apoptotic cells was observed at temperatures of -60 to -50 ºC (Fig. 7C) . At 6 and 12 hr post-thaw, live cell populations continued to "thin out" as delayed death (necrosis and apoptosis) occurred in the periphery of the freeze zone. During this interval, the necrotic staining gradually decreased, yet remained persistent at 24 hr. The apoptotic population, however, appears to reach a nadir at 6 hr with lower, more diffuse staining followed by a dramatic increase in the periphery (around the -20 ºC isotherm) at 12 and 24 hr post-thaw.
Discussion
In this study we employed a novel 3D engineered human prostate tumor model to evaluate the dynamic freeze and cellular response environments associated with cryoablative techniques. We found that the collagen matrices were able to support cell growth and allow for the assessment of cellular behaviors by modifying standard techniques. Though experiments directly focused on cell morphology and gel remodeling were not conducted for this study, cells suspended within the collagen matrix behave in a similar manner to cells in 2D culture. This indicates that there are no adverse effects of such a culture system and any morphological changes or structural remodeling should not hinder post-thaw recovery.
During cryosurgery, the freeze zone formed around the cryoprobes is a highly dynamic environment composed of gradients in ice composition, osmolarity, and temperature. Ranging from around -100 ºC near the probe surface to -0.5 ºC at its edge, the cryolesion contains areas of different thermal stress levels that impact survival. A major limiting factor in cryosurgery relates to the freeze management of the periphery of the freeze zone. Temperatures required to ablate cells, normally -40 ºC, must be reached throughout the targeted tissue and in a surrounding margin to ensure a successful therapeutic outcome (2, 7). The use of an in vitro tissue engineered prostate allows the dynamic properties of a cryolesion to develop and be monitored in real-time and in 3-dimensions similar to clinical settings. Furthermore, by employing various model configurations, volumes equal to actual glandular prostates were achieved allowing temperatures to be mapped and correlated with cell death.
In addition to the procedural characteristics of cryoablation, the engineered model provides for a more in vivo-like environment with the ease of use and assessment of an in vitro system. Cancer cells can be highly plastic and their phenotypes can change depending on the extracellular environment and adjacent cell secretions (13), which makes the 3D culturing of human cancer cells vital to deciphering the exact cellular responses to various treatment modalities. This model approximates an actual tissue (although lacking vasculature), making it possible to evaluate cellular responses over the entire temperature gradient and not just at set, end point temperatures that are achieved with monolayer cultures.
In the case of single vs. double freeze cycles, the utilization of the 3D model allowed us to quantitatively demonstrate what has long been a clinical practice: repetitive freezing is superior to a single treatment. Though a number of theories have been put forth to explain this observation, such as incomplete thawing between cycles leading to more rapid and extensive subsequent freezing, destruction of microcirculation, or increased reperfusion injury, deciphering the exact mechanisms have been difficult. Though it does not rule out other potential causes, for the first time we present data suggesting that the improved outcome of repeated freezing may be due to a sensitization of cells to chilling or freeze-induced changes in the solute concentration in the cryolesion periphery following an initial freeze.
Similar to the effects of repeated freeze cycles is the use of chemotoxic agents in conjunction with cryotherapy (15, (21) (22) (23) . The addition of chemotherapeutic agents sensitize the cells such that additional sub-lethal stresses in the periphery of the lesion yield improved cell death. Though neither the doses of the chemo agents nor the thermal stress in the periphery of the freeze zone are sufficient in destroying the cells, the synergistic effects of sublethal cytotoxic and cryogenic stressors were shown to be effective at ablating the cancer cells. The use of the engineered model allows us to demonstrate for the first time that adjunctive therapies, as with the double freeze cycles, are able to significantly increase the kill volume of the cryogenic lesion. Tissue engineered matrices were frozen by a single, centrally placed 17-gauge cryoprobe and thermocouples at 4 mm intervals extending radially from the center were used to monitor temperatures. Matrices were frozen for a single 10 min freeze followed by a 20 min thaw at 37 ºC.
At 0 hr (prior to freezing), 1 hr, 6 hr, 12 hr, and 24 hr post-thaw matrices were stained with (A) calcein AM (colored blue for clarity, live cells), (B) propidium iodide (red, necrotic cells), and (C) YoPro 1 (green, apoptotic cells). A 50X panoramic series of fluorescent micrographs was taken extending from the center (left of images) to the edge (right of image).
When evaluating the mechanisms of cell death, necrosis or apoptosis, new insights were achieved by using the 3D model system. The classical view of cryoablative cell death is a transitional one with freeze rupture nearest the cryoprobe, necrosis throughout the lesion, and a delayed apoptosis confined primarily to the periphery. Our studies, however, show a different, more dynamic, death pattern. Though the prevalence of necrosis was seen throughout the freeze zone, apoptotic death was not limited to delayed timeframes at the "warmer" isotherms. Rather, a significant amount of apoptotic death could be seen as quickly as 1 hr post-thaw at temperatures as low as -60 ºC. Following this initial burst of apoptosis at -60 ºC, a wave of apoptosis was observed radiating out from the center of the cryogenic lesion as recovery times increased. These data suggest, at least in the case of cryosurgery, that the rate at which apoptosis appears is directly related to the level of stress induced in the cells -the greater the stressor, the more rapid the appearance of apoptosis.
By utilizing the engineered prostate model, we are able to observe an approximation of a tissue section undergoing cryosurgery. The development of cell-cell/matrix attachments in a 3D environment and the assessment of cellular behavior over the entire thermal gradient of the freeze zone in real time affords a more complete view of the cryolesion and corresponding cellular response environments than either animal models or monolayer cultures can achieve. This unique perspective has allowed for the preliminary identification of a sensitization of cells in the freeze zone periphery following a single freeze and a more dynamic apoptotic death.
In summary, by more closely simulating actual in vivo conditions, our tissue engineered 3D prostate model supports more accurate predictions of cell behavior in response to cryosurgery as well as other tumor ablative techniques. The engineered model also provides a platform to which further improvements could be added such as additional cell types or some form of vasculature allowing for an even closer approximation of an actual prostate tumor. Using this model we hope to further explore the biochemical responses of human cancer cells to low temperature insults at levels not possible with standard 2D cultures.
